GSK3-β is considered a key player in AD pathophysiology since dysregulation of this kinase influences the major hallmarks of the disease, including tau phosphorylation, amyloid-β production, memory, neurogenesis, and synaptic function(Lauretti et al., 1867). Here, MAPT is linked to Alzheimer disease.